Abstract:About 26 million people worldwide live with heart failure (HF), and 25% have hypertension (HTN) as the primary cause. These patients have a high risk for cardiac arrhythmias and sudden cardiac death. Autonomic dysfunction and sympathetic hyperactivity accompany these diseases, and sympathetic activation is crucial for triggering fatal arrhythmias. However, changes in cardiac sympathetic innervation in HF are not well understood. We hypothesized that cardiac sympathetic innervation is disrupted in a mouse model of Angiotensin II (AngII)-induced HF. To test this hypothesis, C57BL6 male (N=6, 10) and female (N=6, 10) mice 12-20 weeks old were implanted with minipumps releasing either AngII (712ng/min/Kg, N=6-10) or saline (N=6-10) for 4 weeks. HTN and cardiac function were measured with tail cuff quantification and echocardiography, respectively. Fibrosis was assessed using Trichrome staining. Cardiac sympathetic innervation was quantified using immunohistochemistry for Tyrosine Hydroxylase (TH). Cardiac norepinephrine (NE) was measured by High-Performance Liquid Chromatography with electrochemical detection. Values were compared with a Student’s unpaired t-test unless noted, data were represented as mean ± SD, and significance was defined as p<0.05. AngII-treated mice had significantly increased mean arterial pressure (Saline 91.0±15.6 vs. AngII 152.9±22.3 mmHg, p<0.05, N=6-7) 7 days after minipump implantation. Four weeks of AngII treatment led to HF, as indicated by reduced ejection fraction (Saline 54.8±3.8 vs. AngII 43.1±8.2 %, p<0.05, N=10) and fractional shortening (Saline 14.3±2.6 vs. AngII 10.6±3.3 %, p<0.05, N=10). Cardiac hypertrophy was also observed in AngII-treated mice and was reflected by increased heart weight to body weight ratio (Saline 5.2±0.2 vs. AngII 7.7±1.0, p<0.05, N=6). Fibrosis was detected in the intraventricular septum (IVS) and left ventricle (LV) of AngII-treated mice. TH + fibers in the LV and IVS were decreased significantly (LV: Saline 0.6±0.2 vs. AngII 0.4±0.1 %; IVS: Saline 0.3±0.1 vs. AngII 0.09±0.04 %, p 0.05, N=6). In addition, the subepicardium-subendocardium (EPI-ENDO) gradient was altered (EPI: Saline 0.9±0.2 vs. AngII 0.8±0.3 %, P>0.05; ENDO: Saline 0.3±0.05 vs. AngII 0.1±0.1 %, p<0.05; EPI:ENDO ratio: Saline 2.7±0.7 vs. AngII 15.7±16.8, p<0.05, Mann-Whitney test, N=6). A significant decrease in NE content accompanied the loss of TH + fibers in the LV (LV: Saline 3.9±0.4 vs. AngII 1.6±0.2 pmol/mg, p 0.05, N=4-6). Our data demonstrate that AngII-induced HF disrupts cardiac sympathetic nerve density, distribution, and NE content, confirming our initial hypothesis. This evidence contrasts with sympathetic hyperactivity seen in cardiac diseases. Future studies will assess the overall cardiac innervation and, determine whether the loss of TH + fibers is due to a reduced sympathetic innervation after cardiac remodeling or the cholinergic transdifferentiation of TH + fibers. A better understanding of the cardiac sympathetic nervous system in HF is imperative to deciphering the mechanistic changes to cardiac innervation in disease, and may help to develop and implement novel and precise neuromodulatory therapies for patients with autonomic imbalance. Supported by NIH R01 HL146833 to Dr. Habecker. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Relationship of Cardiac Sympathetic Nerve Innervation and Excitability to Cardiac Hypertrophy in Very Elderly Male Hypertensive Patients

Relationship Between the Changes of Serum Total Testosterone and Sympathetic Nerve Activity in Elderly Hypertensive Males with Cardiac Hypertrophy

Relationship of Cardiac Sympathetic Nerve Distribution with Expression of Nogo-A in Elderly Males with Hypertension and Cardiac Hypertorphy

Relationship between vasoactive substance and blood pressure in old patients with hypertension

Study of Androgen and Atherosclerosis in Old-Age Male

[Atherosclerosis and Androgen Levels in Elderly Males].

Correlativity Between Plasma Brain Natriuretic Peptide Level and Cardial Metrical Indices in Hypertensive Patients

Angiotensin II-Induced Heart Failure Disrupts Cardiac Sympathetic Innervation

Attenuated Sympathetic Blood Pressure Transduction in Patients With Treated Heart Failure With Reduced Ejection Fraction

ADRENERGIC RESPONSIVENESS IS REDUCED, WHILE BASE-LINE CARDIAC-FUNCTION IS PRESERVED IN OLD ADULT CONSCIOUS MONKEYS

Autonomic Nerves in Myocardial Sleeves around Caval Veins: Potential Role in Cardiovascular Mortality?

Gender Differences on the Effects of Aging on Cardiac and Peripheral Adrenergic Stimulation in Old Conscious Monkeys.

Impaired Cardiac Sympathetic Activity Is Associated With Myocardial Remodeling and Established Biomarkers of Heart Failure

Alteration of Cardiac Performance and Serum B-Type Natriuretic Peptide Level in Healthy Aging

Relationship Between Serum Elevation of N-terminal Pro-Brain Natriuretic Peptide and Malnutrition in Very Old Male Patients with Normal Ejection Fraction

The association between serum testosterone level and congestive heart failure in US male adults: data from National Health and Nutrition Examination Survey (NHANES) 2011–2016

Loss of Cardiac Contractile Response to Tetrahydropapaveroline with Advanced Age and Hypertension.

[Synergistic Effect of Hypertension and Aging on Left Atrial Volume and Function].

Cardiac response to adrenergic stress differs by sex and across the lifespan

Sympathetic Neural Control at Rest and During the Cold Pressor Test in Patients With Heart Failure With Preserved Ejection Fraction

The potential role of testosterone in hypertension and target organ damage in hypertensive postmenopausal women.